» Articles » PMID: 20851611

Surgical Treatment for Brain Metastases: Prognostic Factors and Survival in 309 Patients with Regard to Patient Age

Overview
Journal J Clin Neurosci
Specialty Neurology
Date 2010 Sep 21
PMID 20851611
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Brain metastases are the most common intracranial tumors. Overall, the only accepted prognostic factors are patient age and performance status. However, several other factors are considered before surgery. We performed a retrospective analysis of 309 patients who underwent surgical resection of newly diagnosed brain metastases between 1994 and 2004. Univariate survival analysis revealed age, performance status, extracranial metastases, complete resection, radiotherapy and re-craniotomy as prognostic indicators. Multivariate analysis determined that patient age, performance status, extracranial metastases, radiotherapy and re-craniotomy are independent factors of prolonged survival. We statistically estimated the age threshold separating patients with favorable outcomes from those with unfavorable prognoses. Using the Kaplan-Meier analysis this threshold can be set at 65 years. Multivariate analysis of patients >65 years revealed the presence of co-morbidities, the number of brain metastases, post-operative performance status and radiotherapy as independent prognostic factors.

Citing Articles

Neurosurgical management of brain metastases in the elderly: a prospective study on adverse event prevalence and predictors.

Lenga P, Scherer M, Kleineidam H, Unterberg A, Krieg S, Dao Trong P Neurosurg Rev. 2025; 48(1):239.

PMID: 39954148 PMC: 11829898. DOI: 10.1007/s10143-025-03338-y.


Clinical and imaging manifestations of intracerebral hemorrhage in brain tumors and metastatic lesions: a comprehensive overview.

Eminovic S, Orth T, DellOrco A, Baumgartner L, Morotti A, Wasilewski D J Neurooncol. 2024; 170(3):567-578.

PMID: 39222188 PMC: 11614960. DOI: 10.1007/s11060-024-04811-2.


Comparative study of dynamic conformal arc therapy and volumetric modulated arc therapy for treating single brain metastases: A retrospective analysis of dosimetric and clinical outcomes.

Chambrelant I, Jarnet D, Le Fevre C, Kuntz L, Jacob J, Jenny C Phys Imaging Radiat Oncol. 2024; 30:100591.

PMID: 38832123 PMC: 11145388. DOI: 10.1016/j.phro.2024.100591.


Safety of microneurosurgical interventions for superficial and deep-seated brain metastases: single-center cohort study of 637 consecutive cases.

Voglis S, Padevit L, van Niftrik C, Kalin V, Beyersdorf B, Da Mutten R J Neurooncol. 2023; 165(2):271-278.

PMID: 37945819 PMC: 10689541. DOI: 10.1007/s11060-023-04478-1.


Neuroanatomical location of brain metastases from solid tumours based on pathology: An analysis of 511 patients with a comparison to the provided clinical history.

Bonert M, Berzins A, Begum H, Schittenhelm J, Lu J, Juergens R PLoS One. 2023; 18(11):e0294154.

PMID: 37943775 PMC: 10635465. DOI: 10.1371/journal.pone.0294154.